Alkermes plc. Logo

Alkermes plc.

Develops and commercializes medicines for central nervous system (CNS) diseases.

ALKS | US

Overview

Corporate Details

ISIN(s):
IE00B56GVS15 (+1 more)
LEI:
Country:
United States of America
Address:
CONNAUGHT HOUSE, 0 DUBLIN 4

Description

Alkermes plc is a global biopharmaceutical company that develops and commercializes medicines for diseases of the central nervous system (CNS). The company's research and development efforts focus on complex psychiatric and neurological disorders. Its portfolio includes treatments for conditions such as schizophrenia, bipolar I disorder, alcohol dependence, and opioid dependence. Alkermes' clinical-stage pipeline features investigational therapies, including orexin 2 receptor agonists for sleep disorders like narcolepsy and idiopathic hypersomnia. The company's commercialized products include olanzapine and samidorphan, an oral atypical antipsychotic drug for adults with schizophrenia or bipolar I disorder.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-09 01:38 English ZIP 7.2 KB
2026-01-08 23:23
PRIMARY DOCUMENT
English ZIP 7.6 KB
2026-01-06 13:06
8-K
English ZIP 70.8 KB
2026-01-02 22:39
PRIMARY DOCUMENT
English ZIP 6.7 KB
2026-01-02 22:36 English ZIP 7.3 KB
2025-12-05 22:21
PRIMARY DOCUMENT
English ZIP 7.6 KB
2025-12-03 22:32 English ZIP 7.2 KB
2025-12-01 23:41
PRIMARY DOCUMENT
English ZIP 6.7 KB
2025-12-01 22:45 English ZIP 7.2 KB
2025-11-19 12:28
8-K
English ZIP 869.1 KB
2025-11-12 14:45
8-K
English ZIP 7.0 MB
2025-11-03 22:37
PRIMARY DOCUMENT
English ZIP 7.6 KB
2025-11-03 22:35 English ZIP 7.3 KB
2025-10-28 14:20
10-Q
English ZIP 3.4 MB
2025-10-28 12:05
8-K
English ZIP 5.0 MB

Automate Your Workflow. Get a real-time feed of all Alkermes plc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Alkermes plc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Alkermes plc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ANTEROGEN CO., LTD. Logo
Develops and commercializes cell therapies and orphan drugs using adult stem cells.
South Korea
065660
Antibiotice S.A. Logo
Pharmaceutical firm manufacturing generic medicines, anti-infectives, and APIs.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Biopharmaceutical company developing therapies by targeting the complement cascade.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Clinical-stage biopharma developing a bee venom drug and AI digital treasury solutions.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Clinical-stage biotech developing biologics for immunological and inflammatory diseases.
United States of America
APGE
Apollomics Inc. Logo
Clinical-stage biotech developing innovative oncology and combination therapies.
United States of America
APLM
Apontis Pharma AG Logo
Develops and markets fixed-dose combination drugs (Single Pills) for chronic diseases.
Germany
APPH
Applied Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel drugs for rare metabolic and CNS diseases.
United States of America
APLT
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologics and biosimilar antibody-based therapeutics.
South Korea
003060
Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.